We are live on ! Find out more
ATRS

Antares Pharma, Inc.
ATRS

Delisted

ATRS was delisted on the 23rd of May, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of ATRS yet.

ATRS Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Antares Pharma, Inc. (ATRS) for Q4 2022, worth a combined $0 — down 100% from $12K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ATRS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was IFP Advisors, exiting entirely with an estimated $12K sold.

  • 0 institutional investors held Antares Pharma, Inc. (ATRS) as of Q4 2022, down from 1 in Q3 2022.
  • Funds reported $0 of Antares Pharma, Inc. stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Antares Pharma, Inc. positions in Q4 2022 and 1 closed out, a net change of -1 holder.
  • The largest Antares Pharma, Inc. seller in Q4 2022 was IFP Advisors, an estimated $12K sold.

Based on aggregated 13F filings for Q4 2022.